69 related articles for article (PubMed ID: 37643784)
1. Direct programming of human pluripotent stem cells into endothelial progenitors with SOX17 and FGF2.
Ream MW; Randolph LN; Jiang Y; Chang Y; Bao X; Lian XL
Stem Cell Reports; 2024 Apr; 19(4):579-595. PubMed ID: 38518781
[TBL] [Abstract][Full Text] [Related]
2. SOX17: escape route from immune destruction in early CRC.
Papavassiliou KA; Adamopoulos C; Papavassiliou AG
Trends Mol Med; 2024 Apr; ():. PubMed ID: 38594095
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Multi-Cancer Genome Profiling: Data from a Single Hospital in Japan.
Aoyama R; Nishikubo H; Kawabata K; Kanei S; Yamamoto Y; Nishimura S; Yashiro M
Cancer Genomics Proteomics; 2024; 21(1):79-87. PubMed ID: 38151295
[TBL] [Abstract][Full Text] [Related]
4. SOX17 in cellular reprogramming and cancer.
Tan DS; Holzner M; Weng M; Srivastava Y; Jauch R
Semin Cancer Biol; 2020 Dec; 67(Pt 1):65-73. PubMed ID: 31419525
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical Outcomes.
Xu LI; Bai Y; Cheng Y; Sheng X; Sun D
Cancer Genomics Proteomics; 2023; 20(5):433-447. PubMed ID: 37643784
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
8. Identifying SOX17 as a Sensitive and Specific Marker for Ovarian and Endometrial Carcinomas.
Shaker N; Chen W; Sinclair W; Parwani AV; Li Z
Mod Pathol; 2023 Jan; 36(1):100038. PubMed ID: 36788073
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.
Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G
Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.
Chaves-Moreira D; Mitchell MA; Arruza C; Rawat P; Sidoli S; Nameki R; Reddy J; Corona RI; Afeyan LK; Klein IA; Ma S; Winterhoff B; Konecny GE; Garcia BA; Brady DC; Lawrenson K; Morin PJ; Drapkin R
Sci Signal; 2022 Apr; 15(728):eabm2496. PubMed ID: 35380877
[TBL] [Abstract][Full Text] [Related]
13. SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.
Lin L; Shi K; Zhou S; Cai MC; Zhang C; Sun Y; Zang J; Cheng L; Ye K; Ma P; Shen P; Zhang M; Cheng Y; Qi C; Li Y; Yin X; Zheng Y; Tan L; Zhuang G; Zang R
Oncogene; 2022 Mar; 41(12):1767-1779. PubMed ID: 35124696
[TBL] [Abstract][Full Text] [Related]
14. Predicting master transcription factors from pan-cancer expression data.
Reddy J; Fonseca MAS; Corona RI; Nameki R; Segato Dezem F; Klein IA; Chang H; Chaves-Moreira D; Afeyan LK; Malta TM; Lin X; Abbasi F; Font-Tello A; Sabedot T; Cejas P; Rodríguez-Malavé N; Seo JH; Lin DC; Matulonis U; Karlan BY; Gayther SA; Pasaniuc B; Gusev A; Noushmehr H; Long H; Freedman ML; Drapkin R; Young RA; Abraham BJ; Lawrenson K
Sci Adv; 2021 Nov; 7(48):eabf6123. PubMed ID: 34818047
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]